Mike Kelly sold Abbott Laboratories (NYSE: ABT)
Mike Kelly sold ABT · disclosed August 12, 2026
Mike Kelly, a PA House member representing District 16, sold $1,001 - $15,000 of Abbott Laboratories (ABT) on July 17, 2026. Filings associated with Mike Kelly disclosed 0 other ABT transactions in the 12 months before this trade. Shares of ABT have risen 201.4% since the first observed purchase on April 13, 2016. The filing was publicly disclosed on August 12, 2026; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Mike Kelly's complete filing history, visit Mike Kelly's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on ABT break down as 0 strong buy, 20 buy, 0 hold, 0 sell, 0 strong sell.
- ABT carries a Risk Score of 95 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
- Mike Kelly sold ABT in the amount range of $1,001 - $15,000 on July 17, 2026, filed under the STOCK Act.
- The filing lists Spouse as the transaction owner and was disclosed 26 days after the trade.
- The asset description in the filing reads 'Abbott Laboratories Common Stock (ABT) [ST].'
- Filings associated with Mike Kelly disclosed 0 other ABT transactions in the 12 months before this trade.
- Shares of ABT have risen 201.4% since the first observed purchase on April 13, 2016.
- ABT carried a Q Score of 59.7 in its equity peer group as of September 4, 2026.
- ABT carried a Squeeze Score of 15 as of September 8, 2026.
Did Mike Kelly buy or sell ABT?
The Periodic Transaction Report covers a single sale involving ABT on July 17, 2026. The filed amount range is $1,001 - $15,000. The asset description reads 'Abbott Laboratories Common Stock (ABT) [ST]', as submitted by the filer. The report was submitted on August 12, 2026. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Mike Kelly (House) | Sell | ABT | $1,001 - $15,000 | July 17, 2026 | August 12, 2026 |
What other ABT trades has Mike Kelly disclosed in the past 12 months?
Filings associated with Mike Kelly disclosed 0 other ABT transactions in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| No other ABT transactions were disclosed in the prior 12 months. | ||||
What does the filing show, and what does it not show?
The filing reports a sale involving ABT by Mike Kelly in the amount range of $1,001 - $15,000, with Spouse listed as the owner. It does not establish Mike Kelly's total holdings in ABT, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Abbott Laboratories Common Stock (ABT) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Mike Kelly's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Mike Kelly disclosed 0 other ABT transactions in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded ABT?
Quantellect's current database lists these recent ABT disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| Richard Dean Dr McCormick Self | R House | Sell | $1,001 - $15,000 | August 14, 2026Filing unavailable |
| Richard W. Allen Spouse | R House | Sell | $15,001 - $50,000 | August 18, 2026Filing unavailable |
| Rick Larsen Self | D House | Sell | $1,001 - $15,000 | July 12, 2026Filing unavailable |
| Rohit Khanna Spouse | D House | Buy | $1,001 - $15,000 | July 6, 2026Filing unavailable |
| Rohit Khanna Dependent child | D House | Sell | $1,001 - $15,000 | July 6, 2026Filing unavailable |
How has Mike Kelly's disclosed trading performed?
A current measured Q Score is not available for this member. Quantellect does not infer performance where the scored-trade projection lacks coverage.
All Mike Kelly ABT trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did Mike Kelly buy or sell ABT?
According to the disclosure, Mike Kelly sold ABT on July 17, 2026.
What amount was reported for the ABT transaction?
The disclosure reports $1,001 - $15,000 for the sale. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated July 17, 2026, and it was disclosed on August 12, 2026.
Where can I see Mike Kelly's other congressional trades?
Quantellect lists Mike Kelly's complete disclosed trade history on the member profile. Mike Kelly's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.